TY - JOUR
T1 - Acetylcholinesterase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia
AU - Perry, C.
AU - Pick, M.
AU - Podoly, E.
AU - Gilboa-Geffen, A.
AU - Zimmerman, G.
AU - Sklan, E. H.
AU - Ben-Shaul, Y.
AU - Diamant, S.
AU - Soreq, H.
N1 - Funding Information:
This work was supported by grants from the Bat Sheva de Rothschild Career Development Award, the Israel Ministry of Health (to CP), United States–Israel Binational Science Foundation (BSF no. 2003028-01 to CP and HS), the Israeli Ministry of Science Grant (to HS and CP), the EU’s Alternative Splicing Network of Excellence (no. 518238) and the EU’s STREP (LSHG-CT no. 2006-037277) and the Israel/Germany Biodisc Program (to HS). We are grateful to Dr M Crossley (Sydney, Australia) for Ikaros and mCtBP vectors, to Dr R Goodman (Portland, OR) for the hCtBP1 vector and to K Ofek and D Toiber (Jerusalem) for assistance in experiments. This work was done at The Hebrew University of Jerusalem and the Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
PY - 2007/7
Y1 - 2007/7
N2 - Hematological changes induced by various stress stimuli are accompanied by replacement of the primary acetylcholinesterase (AChE) 3′ splice variant acetylcholinesterase-S (AChE-S) with the myelopoietic acetylcholinesterase-R (AChE-R) variant. To search for putative acetylcholinesterase-S interactions with hematopoietic pathways, we employed a yeast two-hybrid screen. The transcriptional co-repressor C-terminal binding protein (CtBP) was identified as a protein partner of the AChE-S C terminus. In erythroleukemic K562 cells, AChE-S displayed nuclear colocalization and physical interaction with CtBP. Furthermore, co-transfected AChE-S reduced the co-repressive effect of CtBP over the hematopoietic transcription factor, Ikaros. In transgenic mice, overexpressed human (h) AChE-S mRNA induced selective bone marrow upregulation of Ikaros while suppressing FOG, another transcriptional partner of CtBP. Transgenic bone marrow cells showed a correspondingly elevated potential for producing progenitor colonies, compared with controls, while peripheral blood showed increased erythrocyte counts as opposed to reduced platelets, granulocytes and T lymphocytes. AChE's 3′ alternative splicing, and the corresponding changes in AChE-S/ CtBP interactions, thus emerge as being actively involved in controlling hematopoiesis and the potential for modulating immune functions, supporting reports on malfunctioning immune reactions under impaired splice site selection.
AB - Hematological changes induced by various stress stimuli are accompanied by replacement of the primary acetylcholinesterase (AChE) 3′ splice variant acetylcholinesterase-S (AChE-S) with the myelopoietic acetylcholinesterase-R (AChE-R) variant. To search for putative acetylcholinesterase-S interactions with hematopoietic pathways, we employed a yeast two-hybrid screen. The transcriptional co-repressor C-terminal binding protein (CtBP) was identified as a protein partner of the AChE-S C terminus. In erythroleukemic K562 cells, AChE-S displayed nuclear colocalization and physical interaction with CtBP. Furthermore, co-transfected AChE-S reduced the co-repressive effect of CtBP over the hematopoietic transcription factor, Ikaros. In transgenic mice, overexpressed human (h) AChE-S mRNA induced selective bone marrow upregulation of Ikaros while suppressing FOG, another transcriptional partner of CtBP. Transgenic bone marrow cells showed a correspondingly elevated potential for producing progenitor colonies, compared with controls, while peripheral blood showed increased erythrocyte counts as opposed to reduced platelets, granulocytes and T lymphocytes. AChE's 3′ alternative splicing, and the corresponding changes in AChE-S/ CtBP interactions, thus emerge as being actively involved in controlling hematopoiesis and the potential for modulating immune functions, supporting reports on malfunctioning immune reactions under impaired splice site selection.
UR - http://www.scopus.com/inward/record.url?scp=34250726519&partnerID=8YFLogxK
U2 - 10.1038/sj.leu.2404722
DO - 10.1038/sj.leu.2404722
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 17476278
AN - SCOPUS:34250726519
SN - 0887-6924
VL - 21
SP - 1472
EP - 1480
JO - Leukemia
JF - Leukemia
IS - 7
ER -